Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies Inc.
WKN: A2AJW8 / Symbol: ADVM / Name: Adverum Bio / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,38 €
-2,65 %
Sell Avalanche Biotechnologies Inc.
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $6.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) is now covered by analysts at Mizuho. They set a "buy" rating and a $2.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target raised by analysts at Mizuho from $2.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target lowered by analysts at Mizuho from $40.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $30.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $60.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $25.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target raised by analysts at Chardan Capital from $4.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target lowered by analysts at Truist Financial Co. from $60.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Varonis Systems Inc. diskutieren